Sign in →

Test ID FSULF Sulfatide Autoantibody Test

Method Name

Enzyme-Linked Immunosorbent Assay (ELISA)

Reporting Name

Sulfatide Autoantibody Test

Specimen Type

Serum

Draw blood in a plain, red-top tube(s), serum gel tube is acceptable. Spin down and send 2 mL of serum refrigerated in a plastic vial.

Specimen Minimum Volume

0.5 mL

Specimen Stability Information

Specimen Type Temperature Time
Serum Refrigerated (preferred) 21 days
  Frozen  120 days
  Ambient  72 hours

Clinical Information

Background information: Peripheral neuropathies (PNs) are a group of neurological disorders affecting one or more of the peripheral nerves (1,2). Causes of PN include nerve compression, genetic mutations, inflammation, metabolic abnormalities, vitamin deficiencies, exposure to toxins or drugs, or the presence of autoimmune antibodies (1). Symptoms of PN vary based on location and mechanism of nerve damage but can include sensory impairment, distal weakness, loss of sensation, muscle weakness, and pain (1,2). PNs are typically classified based on the types of nerves affected, predominantly motor, predominantly sensory, or a combination of both (2).

IgG and more commonly IgM Antibodies to sulfatide have been associated with sensory and sensory-motor neuropathies sometimes accompanied by pain (3,4,5). Additionally, IgG anti-sulfatide antibodies have been associated with distal sensory polyneuropathy (DSP) in individuals with HIV (6).

Reference Values

Interpretive Criteria

Interpretation and Comments provided on each report. They are dependent upon results.

 

Reference Range:

 

anti-Sulfatide IgG: Negative <1:2000

                     Borderline*

                     Positive ≥ 1:2000

 

anti-Sulfatide IgM: Negative <1:2000

                      Borderline*

                      Positive ≥ 1:2000

 

*Samples in the borderline range have an elevated level of anti-sulfatide antibodies on the screen assay, but the level of antibodies is below the positive cut off value.

 

Cautions

Limitations of analysis: Although rare, false positive or false negative results may occur. All results should be interpreted in the context of clinical findings, relevant history, and other laboratory data.

Day(s) Performed

Upon receipt

Report Available

7 - 14 days

Performing Laboratory

Athena Diagnostics

Test Classification

This test was developed and its performance characteristics have been determined by Athena Diagnostics. Performance characteristics refer to the analytical performance of the test.

CPT Code Information

83520 x2 Immunoassay, analyte, quant; not otherwise specified

NY State Approved

Yes